TY  - GEN
AU  - Fontana,D
AU  - Mari,M
AU  - Martinelli,A
AU  - Boccafoschi,C
AU  - Magno,C
AU  - Turriziani,M
AU  - Maymone,S S
AU  - Cunico,S Cosciani
AU  - Zanollo,A
AU  - Montagna,G
AU  - Frongia,M
AU  - Jacobellis,U
TI  - 3-month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: results from an Italian, open, multicenter trial
SN  - 0042-1138
PY  - 2003///0829
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents, Hormonal
KW  - administration & dosage
KW  - Delayed-Action Preparations
KW  - Goserelin
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Male
KW  - Middle Aged
KW  - Prostate-Specific Antigen
KW  - blood
KW  - Prostatectomy
KW  - Prostatic Neoplasms
KW  - Testosterone
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1159/000070142
ER  -